Charles Hugh-Jones
Chief Executive Officer chez Volastra Therapeutics, Inc.
Profil
Charles Hugh-Jones is currently the Chief Executive Officer at Volastra Therapeutics, Inc. He was previously the Chief Medical Officer at Allergan Ltd.
(Ireland) from 2018 to 2020.
Prior to that, he worked at Addleshaw Booth & Co. from 2004 to 2007.
Postes actifs de Charles Hugh-Jones
Sociétés | Poste | Début |
---|---|---|
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Chief Executive Officer | - |
Anciens postes connus de Charles Hugh-Jones
Sociétés | Poste | Fin |
---|---|---|
ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 08/05/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Health Technology |